Aviragen Therapeutics
Research, 2500 Northwinds Pkwy, Alpharetta, Georgia, 30009, United States, 51-200 Employees
Phone Number: +16*********
Who is AVIRAGEN THERAPEUTICS
Aviragen Therapeutics is focused on the discovery and development of the next generation of direct-acting antivirals to treat infections that have limited therapeutic options and affect a...
Read More
-
Headquarters: 2500 Northwinds Pkwy, Alpharetta, Georgia, 30009, United States
-
Date Founded: 1984
-
Employees: 51-200
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
-
CEO:
David Zutler
Email
Phone
SIC Code: 
Does something look wrong? Fix it. | View contact records from AVIRAGEN THERAPEUTICS
Aviragen Therapeutics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Aviragen Therapeutics
Answer: Aviragen Therapeutics's headquarters are located at 2500 Northwinds Pkwy, Alpharetta, Georgia, 30009, United States
Answer: Aviragen Therapeutics's phone number is +16*********
Answer: Aviragen Therapeutics's official website is https://aviragentherapeutics.com
Answer: Aviragen Therapeutics's revenue is $10 Million to $25 Million
Answer: Aviragen Therapeutics's SIC: 2834
Answer: Aviragen Therapeutics's NAICS: 325412
Answer: Aviragen Therapeutics has 51-200 employees
Answer: Aviragen Therapeutics is in Research
Answer: Aviragen Therapeutics contact info: Phone number: +16********* Website: https://aviragentherapeutics.com
Answer: Aviragen Therapeutics is focused on the discovery and development of the next generation of direct-acting antivirals to treat infections that have limited therapeutic options and affect a significant number of patients globally. The Company has three Phase 2 clinical stage compounds: vapendavir, a capsid inhibitor for the prevention or treatment of rhinovirus (RV) upper respiratory infections; enzaplatovir (BTA585), a fusion protein inhibitor in development for the treatment of respiratory syncytial virus infections; and BTA074, an antiviral treatment for condyloma caused by human papillomavirus types 6 & 11.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month